Rx Processing Corp. Expanding Website Architecture 5/12/2006 11:46:26 AM WILMINGTON, DE, May 12, 2006 (MARKET WIRE via COMTEX) -- Rx Processing Corporation ( RXPC ), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans who are under-insured or have no prescription insurance coverage, is expanding the online website architecture for www.rxprocessingcorp.com directed by a Los Angeles-based web design team.
Rx Processing Corp.'s online expansion is focused with three major components; Integration of Prescription Medication and Laboratory Testing ordering systems, Health and Wellness education, and Regulatory Alerts section. Our corporate action delivers consumers ordering transparency, establishes an information source to acquire healthcare knowledge and develops a process to help regulators.
Peter Fiorillo CEO, Rx Processing stated, "Providing a simplified healthcare ordering environment helps address the justified safety concerns affecting U.S. citizens buying necessary healthcare products from domestic and international sources."
Three hundred and fifty thousand (350,000) shares of restricted common stock were issued for the advanced website architecture in March 2006 and we anticipate the new site posted on July 4, 2006.
[ May 12, 2006, 23:49: Message edited by: J_U_ICE ]
-------------------- The difference between genius and stupidity is that genius has its limits
IP: Logged |
Rx Processing Corp. Retiring the Majority of Issued and Outstanding Common Stock Friday March 24, 8:00 am ET
WILMINGTON, DE--(MARKET WIRE)--Mar 24, 2006 -- Rx Processing Corporation (Other OTC:RXPC.PK - News), a source of low-cost prescription medications for millions of Americans who are under-insured or have no prescription insurance coverage, recognized a commitment to shareholder value by motivating shareholders to retire a significant amount of common stock. Rx Processing Corp. asked insiders and shareholders to retire common stock to reduce the issued and outstanding shares in an ongoing effort to secure the company from short positions and market manipulation. The response was overwhelmingly positive; shareholders thus far have retired 78 million shares from a high point of about 189 million "Feb 06." The company is committed to retire, an additional 54.35 million shares, currently in process.
Peter Fiorillo commented, "Our company actions, diligently increasing shareholder value by retiring shareholders stock, protect our capital interests as we build investor confidence and value today and in the future."
Rx Processing is positioned to become a market leader in providing prescription medications and preventive health laboratory tests to U.S. citizens, corporations, and members, through CLIA-certified patient service centers, for their lab testing and licensed pharmacies in the United States and around the world. The company provides access to approved brand-name and generic medications, and hundreds of lab tests with access to 4,000+ CLIA-certified patient service centers for their lab testing. Rx Processing Corp. estimates that more than 44 million United States Citizens could benefit from the company's affordable prescription medication and laboratory testing programs.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
Rx Processing Corp. Engages Accounting / Bookkeeping Firm, Intercontrollers, Inc. Thursday May 11, 7:09 am ET
WILMINGTON, DE--(MARKET WIRE)--May 11, 2006 -- Rx Processing Corporation (Other OTC:RXPC.PK - News), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans who are under-insured or have no prescription insurance coverage, recently engaged Intercontrollers, Inc. Accounting and Bookkeeping services, to provide financial information.
Rx Processing Corp.'s engagement with Intercontrollers, Inc. represents an accounting / bookkeeping process which strengthens our transparency and protects our corporate interests. Outsourcing Accounts Payable, Accounts Receivable, Bank Reconciliations, General ledger maintenance, and Financial Statements Preparation / Reporting is the right direction for accurate delivery of financial reports and regulatory filings and potential dividends.
Peter Fiorillo, CEO of Rx Processing Corp., stated, "Our engagement of Intercontrollers, Inc. provides a cost-controlled solution that makes corporate reporting a reality for our emerging corporation.
"Rx Processing Corp. represents peace, freedom and pursuit of the American Dream, against all odds."
Rx Processing is positioned to become a market leader in providing prescription medications and preventive health laboratory tests to U.S. citizens, corporations, and members, through CLIA-certified patient service centers, for their lab testing and licensed pharmacies in the United States and around the world. The company provides access to approved brand-name and generic medications, and hundreds of lab tests with access to 4,000+ CLIA-certified patient service centers for their lab testing. Rx Processing Corp. estimates that more than 44 million United States Citizens could benefit from the company's affordable prescription medication and laboratory testing programs.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
Contact: CONTACT: Rx Processing Corp. Peter Fiorillo (800) 576-7055 http://Rxprocessingcorp.com Rx Processing Corp. Announces Agreement Resolving Past Litigation Wednesday May 10, 10:04 am ET
WILMINGTON, DE--(MARKET WIRE)--May 10, 2006 -- Rx Processing Corporation (Other OTC:RXPC.PK - News), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans who are under-insured or have no prescription insurance coverage, is actively finalizing a stipulated final judgment to amicably resolve pending litigation filed against George Donnelly and D&M Enterprises in April 2005.
Rx Processing Corp and George Donnelly are prevailing peacefully in negotiating the ending of a suit filed in 2005, contesting previous actions while acting as Chief Operating Officer of Rx processing Corp. Our collective action signals a common message to shareholder's that disagreeing parties can co-exist as allies rather than adversaries in servicing clients in this emerging market. In our on-going mission, RXPC continues to enhance the distribution and sourcing of prescription medications and laboratory testing to all clients. The building of team relationships and redundant networks continues to serve the under and uninsured while peacefully furthering the mission of achieving affordable health care. Through the establishment of a non-contested corporation, owned by George Donnelly we can collectively strive towards achievement of a common goal.
Peter Fiorillo stated, "Protecting shareholder value and continuing the pursuit of making health care more affordable to the under and uninsured is job one. Rx Processing Corp will be receiving back 5,000,000 shares of RXPC common stock originally issued. George Donnelly will move forward with D&M Enterprises Inc. the public will gain two strong independent groups working daily to service the health care needs of our citizens."
"Rx processing Corp anticipates the stipulated final judgment closing by June 15th, 2006."
Rx Processing is positioned to become a market leader in providing prescription medications and preventive health laboratory tests to U.S. citizens, corporations, and members, through CLIA-certified patient service centers, for their lab testing and licensed pharmacies in the United States and around the world. The company provides access to approved brand-name and generic medications, and hundreds of lab tests with access to 4,000+ CLIA-certified patient service centers for their lab testing. Rx Processing Corp. estimates that more than 44 million United States Citizens could benefit from the company's affordable prescription medication and laboratory testing programs.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated. Rx Processing Corp is working diligently to have the stipulated final judgment. signed in a 'Language' which Peter Fiorillo and George Donnelly negotiated during telephone conversations over the past six weeks. Rx Processing Corp reserves the right not to execute or sign the stipulated final judgment.
Rx Processing Corp. on Track to Complete Direct Labs Services Inc. Acquisition
Update: 4:01 PM ET Feb 22, 2006
WILMINGTON, DE, Feb 22, 2006 (MARKET WIRE via COMTEX) -- Rx Processing Corporation (RXPC : rx processing corp com News , chart, profile, more Last: 0.11+0.07+175.00%
6:41pm 05/12/2006
RXPC0.11, +0.07, +175.0%) , a leading source of low-cost prescription medications for millions of Americans who are under-insured or have no prescription insurance coverage, will complete acquisition of Direct Lab Services Inc. in second quarter 2006. Rx Processing Corp. optioned in 2005 for the acquisition of Direct Laboratory Services Inc., a 17-year-old Louisiana company, a pioneer and innovator in the Direct Access Laboratory testing Industry. This strategic acquisition will help us provide U.S. citizens more personal control over their wellness testing needs including CBCs, PSAs, and a host of blood test panels. Direct Labs Services is a multi-million-dollar acquisition with limited competition, strength in its intellectual property, and an effective competitor in this market. Due diligence performed on Direct Labs Services Inc., verified all claims that warrant and support the 4 million dollar acquisition with a few welcomed surprises. Of note, a contract with the State of Louisiana Office of Group benefits (260+ thousand clients), the credentialing as a Health Savings Account (HSA) provider and enough cash in the bank to pay laboratory vendors 6 months in advance for client services ordered in 2006. Peter Fiorillo commented, "This acquisition broadens our ability to deliver value added laboratory service products and focus on helping to stabilize and support traditional domestic prescription medication supply lines. These added services will enhance support of independent pharmacies, sustain local markets through high margin residual ordering of laboratory products, and allow U.S. Citizens access to laboratory testing from their trusted health care provider." John Bell, founder of Direct Laboratory Services, stated, "My interest in selling solidifies the future of this company and the Direct Access Laboratory Testing industry. My continued support of Rx Processing Corp. as a shareholder and corporate officer, post acquisition, will further guide the principles at the helm, ensure our future success and provide needed health care benefits to our current and future clients." http://www.rxprocessingcorp.com About Rx Processing Rx Processing is positioned to become a market leader in providing prescription medications and preventive health laboratory tests to U.S. citizens, corporations, and members, through CLIA-certified patient service centers, for their lab testing and licensed pharmacies in the United States and around the world. The company provides access to approved brand-name and generic medications, and hundreds of lab tests with access to 4,000+ CLIA-certified patient service centers for their lab testing. Rx Processing Corp. estimates that more than 44 million United States Citizens could benefit from the company's affordable prescription medication and laboratory testing programs. Safe Harbor Statement All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated. CONTACT: Rx Processing Corp. Peter Fiorillo (800) 576-7055 http://Rxprocessingcorp.com SOURCE: Rx Processing Corp. http://Rxprocessingcorp.com Copyright 2006 Market Wire, All rights reserved.
-------------------- The difference between genius and stupidity is that genius has its limits
IP: Logged |
posted
Looks like they used their money wisely for the website; very professional. This one is now on my watch list.
Energy stocks may be the "big guns" right now, but with an aging population and healthcare costs continually rising, healthcare associated services will always be a hot commodity...JMO
Rx Processing Corp. Streamlines Corporate Business Plan With a Focused Mission Wednesday February 1, 2:23 pm ET
WILMINGTON, DE--(MARKET WIRE)--Feb 1, 2006 -- Rx Processing Corporation (Other OTC:RXPC.PK - News), a leading source of low-cost prescription medications for millions of Americans who are under-insured or have no prescription insurance coverage, streamlines its business plan to motivate individuals by taking action that will positively affect their health care.
Rx Processing Corp. continues the transition by focusing all corporate efforts on underinsured and uninsured U.S. Citizens. Our focused mission, "Affecting personal control of healthcare, where individuals are motivated to take action to undergo regular diagnosis and treatment for their longevity" solidifies the future position of our corporation as we provide healthcare products and services. The business plan has been re-architected during the last two months to capitalize on the expanding healthcare market. It is through our actions of open and transparent market communications that we will achieve this common goal.
As accomplished innovators in this industry we continue to contribute to the ever-changing healthcare environment and develop methods of service. The under or uninsured will have continued access to the essential healthcare products and services. The corporate business plan we are filing with the SEC is our guide for investors to evaluate our fundamental business structure and evaluate the company's execution of its plan as Rx Processing Corp. delivers results to those citizens in need.
Peter Fiorillo commented, "My commitment to the future success of Rx Processing Corp. has never been more apparent in today's society. As Chairman /CEO of our company, I have been attacked daily by market manipulators, unethical business leaders and corporate pirates from around the world. Today, I lead you with these experiences and knowledge to give back to under and uninsured U.S. Citizens the benefits they so justly deserve
posted
Keep a eye on this one down to .057 up 14% today on almost 6x volume news on the merger could be coming
CEO says merger to be complete by June 15
Rx Processing Corp. on Track to Complete Direct Labs Services Inc. Acquisition
Update: 4:01 PM ET Feb 22, 2006
WILMINGTON, DE, Feb 22, 2006 (MARKET WIRE via COMTEX) -- Rx Processing Corporation (RXPC : rx processing corp com News , chart, profile, more Last: 0.11+0.07+175.00%
6:41pm 05/12/2006
RXPC0.11, +0.07, +175.0%) , a leading source of low-cost prescription medications for millions of Americans who are under-insured or have no prescription insurance coverage, will complete acquisition of Direct Lab Services Inc. in second quarter 2006. Rx Processing Corp. optioned in 2005 for the acquisition of Direct Laboratory Services Inc., a 17-year-old Louisiana company, a pioneer and innovator in the Direct Access Laboratory testing Industry. This strategic acquisition will help us provide U.S. citizens more personal control over their wellness testing needs including CBCs, PSAs, and a host of blood test panels. Direct Labs Services is a multi-million-dollar acquisition with limited competition, strength in its intellectual property, and an effective competitor in this market. Due diligence performed on Direct Labs Services Inc., verified all claims that warrant and support the 4 million dollar acquisition with a few welcomed surprises. Of note, a contract with the State of Louisiana Office of Group benefits (260+ thousand clients), the credentialing as a Health Savings Account (HSA) provider and enough cash in the bank to pay laboratory vendors 6 months in advance for client services ordered in 2006. Peter Fiorillo commented, "This acquisition broadens our ability to deliver value added laboratory service products and focus on helping to stabilize and support traditional domestic prescription medication supply lines. These added services will enhance support of independent pharmacies, sustain local markets through high margin residual ordering of laboratory products, and allow U.S. Citizens access to laboratory testing from their trusted health care provider." John Bell, founder of Direct Laboratory Services, stated, "My interest in selling solidifies the future of this company and the Direct Access Laboratory Testing industry. My continued support of Rx Processing Corp. as a shareholder and corporate officer, post acquisition, will further guide the principles at the helm, ensure our future success and provide needed health care benefits to our current and future clients." http://www.rxprocessingcorp.com About Rx Processing Rx Processing is positioned to become a market leader in providing prescription medications and preventive health laboratory tests to U.S. citizens, corporations, and members, through CLIA-certified patient service centers, for their lab testing and licensed pharmacies in the United States and around the world. The company provides access to approved brand-name and generic medications, and hundreds of lab tests with access to 4,000+ CLIA-certified patient service centers for their lab testing. Rx Processing Corp. estimates that more than 44 million United States Citizens could benefit from the company's affordable prescription medication and laboratory testing programs. Safe Harbor Statement All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated. CONTACT: Rx Processing Corp. Peter Fiorillo (800) 576-7055 http://Rxprocessingcorp.com SOURCE: Rx Processing Corp. http://Rxprocessingcorp.com Copyright 2006 Market Wire, All rights
-------------------- The difference between genius and stupidity is that genius has its limits
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
